Laser blood test could spot diabetes in minutes
NCT ID NCT06862778
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This completed study tested whether a special laser technique called surface-enhanced Raman spectroscopy (SERS) can diagnose diabetes from a blood sample. Researchers analyzed blood from 52 people (healthy and diabetic) to see if the laser could tell them apart. The goal is to develop a quick, simple diagnostic tool that could replace traditional blood tests.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- Surface-enhanced Raman spectroscopy (SERS) liquid biopsy
- What this could lead to
- If successful, this could lead to a faster, needle-free way to diagnose diabetes using just a drop of blood.
- What could go wrong
- This was a very small, early exploratory study with only 52 participants. The technique may not be accurate enough for real-world use and needs much larger testing.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
RWTH Aachen university hospital
Aachen, 52074, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Text messages and nurses: a new strategy to tackle hypertension in tanzania?
- Could diabetes be silently damaging your hearing?
- Press play on better health: could recording doctor visits boost Self-Care in seniors?
- Putting Patients' priorities first: a new approach to ease the burden of multiple chronic illnesses
- A simple card game could transform diabetes care
- Can a new injection help tackle obesity and diabetes? a safety trial begins